ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 791,79
0,64%
Dow Jones
42 313,00
0,33%
DAX
19 473,63
1,32%
Brent Oil
71,925
1,37%
Bitcoin
65 719,04
0,82%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Science 37 Holdings Inc (SNCE)

  7. Science 37 Holdings Inc (SNCE) Actualités

SNCE

Science 37 (SNCE)

Science 37 Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SNCE
DateHeureSourceTitreSymboleSociété
16/09/202414h00GlobeNewswire Inc.Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical TrialsNASDAQ:SNCEScience 37 Holdings Inc
06/08/202414h00GlobeNewswire Inc.Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NCNASDAQ:SNCEScience 37 Holdings Inc
18/07/202414h00GlobeNewswire Inc.Science 37 Enrolls 42% of Trial Cohort in 8 WeeksNASDAQ:SNCEScience 37 Holdings Inc
27/06/202415h41GlobeNewswire Inc.Science 37 Quickly Impacts Performance in Under-Enrolling Clinical TrialsNASDAQ:SNCEScience 37 Holdings Inc
12/06/202421h55GlobeNewswire Inc.CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
12/06/202414h00GlobeNewswire Inc.Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
13/05/202414h00GlobeNewswire Inc.Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceNASDAQ:SNCEScience 37 Holdings Inc
09/05/202416h00GlobeNewswire Inc.Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”NASDAQ:SNCEScience 37 Holdings Inc
02/05/202414h00GlobeNewswire Inc.Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
17/04/202414h00GlobeNewswire Inc.Science 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentNASDAQ:SNCEScience 37 Holdings Inc
12/03/202411h45PR Newswire (US)eMed completes tender offer for all outstanding shares of Science 37NASDAQ:SNCEScience 37 Holdings Inc
04/03/202412h18Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
04/03/202412h01Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
20/02/202405h16PR Newswire (US)Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law FirmNASDAQ:SNCEScience 37 Holdings Inc
12/02/202415h03Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SNCEScience 37 Holdings Inc
12/02/202414h16Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SNCEScience 37 Holdings Inc
12/02/202413h45PR Newswire (US)eMed commences tender offer for Science 37NASDAQ:SNCEScience 37 Holdings Inc
09/02/202413h49Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:SNCEScience 37 Holdings Inc
09/02/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
30/01/202416h11Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:SNCEScience 37 Holdings Inc
12/12/202314h00GlobeNewswire Inc.Science 37 Receives Top Honors in Everest PEAK Matrix®NASDAQ:SNCEScience 37 Holdings Inc
07/12/202322h59GlobeNewswire Inc.Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNCEScience 37 Holdings Inc
05/12/202313h00GlobeNewswire Inc.Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023NASDAQ:SNCEScience 37 Holdings Inc
07/11/202312h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SNCEScience 37 Holdings Inc
07/11/202312h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNCEScience 37 Holdings Inc
27/10/202322h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
10/10/202322h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNCEScience 37 Holdings Inc
03/10/202322h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
20/09/202313h59GlobeNewswire Inc.Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 ListNASDAQ:SNCEScience 37 Holdings Inc
13/09/202313h59GlobeNewswire Inc.Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023NASDAQ:SNCEScience 37 Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SNCE

Dernières Valeurs Consultées

COIN
COCOUST
0xCoco
USOTC
WHTAF
WashTec (PK)
TG
ODF
Old Dominion Freight Line
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés